Antithrombotic therapy decisions in palliative care
This study asks doctors who care for patients in palliative care about how they make complex decisions regarding blood-thinning medications. Your answers could help improve guidance for these difficult choices.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a doctor.
- You practice in Italy.
- You are a member of a major Italian medical society focused on blood-thinning treatments.
- You care for patients in palliative care.
- You are willing to complete an online questionnaire.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how blood-thinning medicines are used in people receiving palliative care near the end of life. It aims to find the best way to manage these medicines to improve comfort and quality of life.
This survey study explores oral health in people receiving palliative care. By answering a questionnaire, you can help improve care and comfort for patients with serious illness.
This study aims to create a questionnaire for patients who have had their spleen removed (splenectomy). The questionnaire will help doctors better understand and manage these patients' health needs.
This study looks at how people with cancer-related blood clots in the leg or lungs do with anticoagulant (blood thinner) treatment over at least 3 months. It also tracks quality of life and healthcare use, which may help improve supportive care for patients.
This study tests a tool that helps patients and doctors decide together which blood thinner treatment to use after a heart attack and stent placement, especially for people with higher bleeding risk. The tool is meant to help you understand your options and make a choice that fits your health needs.
This study builds a registry by asking adults who take blood thinners (anticoagulants) about their experiences. It may help improve care by learning how these medicines are used in real life.
Hear when a new Palliative Care trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.